Coronavirus Clinical Trials 2022

Coronavirus studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect coronavirus clinical trial in 2022.

Filter Clinical TrialsFilter Clinical Trials

LOCATION

Anywhere

FILTER TRIALS

casirivimab+imdevimab

The primary objective of the study is to characterize the concentrations of casirivimab+imdevimab in serum over time after a single subcutaneous (SC) administration The secondary objectives of the study are: To assess the safety and tolerability of SC or single administration of casirivi…

Primary Objectives Phase 1 (Safety and Tolerability) • Evaluate the safety and tolerability of REGN14256+imdevimab and REGN14256 monotherapy, as measured by treatment-emergent adverse events (TEAEs), injection-site reactions (ISRs), and hypersensitivity reactions Phase 1/2 (Virologic Eff…

This study is evaluating whether baricitinib is safe and effective in hospitalized pediatric participants with COVID-19.

casirivimab and imdevimab

This study is evaluating whether a drug called casirivimab can be safely given to people with cancer.

This study is evaluating whether a drug called sotrovimab can help treat people with mild/moderate COVID-19.

casirivimab+imdevimab combination therapy

Phase 1 To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral load of SARS-CoV-2 Phase 2 • To evaluate the virologic efficacy of REGN10933+REGN10987 compared to p…

CloSYS Ultra Sensitive Rinse mouthwash

In this pilot trial, 150 confirmed COVID-19 individuals will be randomly assigned to 1 of 5 groups: distilled water, CloSYS Ultra Sensitive Rinse (Rowpar Pharmaceutical Inc., USA), Oral-B Mouth Sore (Oral-B, USA), Crest Pro-Health Multi-Protection (Crest, USA), or Listerine Zero (Johnson a…

This study is evaluating whether a combination of hydroxychloroquine and azithromycin is more effective than hydroxychloroquine alone in reducing the clinical progression of COVID-19.

Remdesivir (antiviral)

This study is evaluating whether investigational medications can be used to treat COVID-19.

The purpose of this study is to evaluate the extent to which a single session of light to moderate intensity exercise performed within 30 minutes after receiving the third dose (booster dose) of coronavirus disease 2019 (COVID-19) vaccine may modify the immune response to vaccination, and …

Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use

The study consists of a randomized controlled trial evaluating the efficacy and feasibility of a stepped alcohol treatment using telemedicine on unhealthy alcohol use in patients with chronic liver disease receiving care in hepatology practices at three sites. Patients who meet eligibility…

casirivimab+imdevimab

The primary objectives of the study are: To characterize the concentrations of casirivimab+imdevimab in serum over time To evaluate the safety and tolerability of casirivimab+imdevimab The secondary objective of the study is: • To assess the immunogenicity of casirivimab+imdevimab

Sacubitril / Valsartan Oral Tablet [Entresto]

This study is evaluating whether sacubitril/valsartan may help reduce the risk of heart failure in individuals who have had a heart attack.

This study is evaluating whether a training program may help health care workers deal with stress during a pandemic.

This study is evaluating whether a drug may help prevent or treat acute respiratory distress syndrome.

This study is evaluating whether a drug called OP-101 can be used to treat COVID-19.

This study is evaluating whether a drug may help individuals with a rare lung disease.

The primary hypothesis is that concomitant administration of the first doses of 9vHPV vaccine and 2-dose regimen of mRNA-1273 vaccine induces noninferior geometric mean titers (GMTs) of antibodies to each of the 9vHPV vaccine types at 4 weeks postdose 2 of 9vHPV vaccine AND noninferior geo…

This study is evaluating whether there is consistency in the immunogenicity of three lots of Coronavirus-like Particle (CoVLP).

Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)

This study is evaluating whether a single infusion of anti-coronavirus immunoglobulin can improve clinical status in people with COVID-19.

Continuous Glucose Monitor (CGM)

This study is evaluating whether continuous glucose monitors are as accurate as point of care glucose monitors.

This study is evaluating whether a drug may help reduce the risk of death or need for a breathing machine in individuals with a certain type of pneumonia.

This study is evaluating whether a drug may help reduce the risk of blood clots in patients with a common virus.

This study is evaluating whether a new drug may help treat coronavirus.

This study is evaluating whether a drug may help reduce the risk of developing symptoms of Chagas disease.

Pfizer-BioNTech mRNA COVID-19 vaccine

This trial is being completed to understand whether people with a history of an adverse reaction to the first or second dose of either the Pfizer-BioNTech COVID-19 vaccine or the Moderna COVID-19 vaccine can safely tolerate an additional dose or if individuals with a personal history of al…

This study is evaluating whether a set of activities can improve sleep habits in people with dementia.

This study is evaluating whether a drug called molnupiravir can prevent COVID-19 infection in people who live with someone who has COVID-19.

MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)

This study is evaluating whether a drug may help reduce inflammation and improve outcomes for individuals with novel coronavirus pneumonia.

This study is evaluating whether a drug may help treat SARS.

COVID 19 Convalescent Plasma

This study is evaluating whether convalescent plasma is safe and effective for treating COVID-19.

This study is evaluating whether a drug may help reduce the severity of symptoms of COVID.

This study is evaluating whether a medication may help treat acute lung injury.

This study is evaluating whether a drug may help treat a rare lung disease.

This study is evaluating whether a set of activities can improve symptoms of post COVID syndrome.

The purpose of this project is to study the impact of Osteopathic Manipulative Medicine (OMM) treatments, such as lymphatic myofascial release and thoracic pump techniques severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels in patients who receive the mR…

This study is evaluating whether a drug may help treat people with a certain type of pneumonia.

Vaccinated with polio vaccine (IPV)

A total of 300 healthy volunteers between the ages of 18 and 80 with no previous history of COVID-19 will be entered into the study and will receive IPV by injection on Day 1. Blood specimens collected pre-inoculation will be tested for cross-reactivity to poliovirus and SARS-CoV-2 by West…

SARS-CoV-2 is a member of a class of viruses: angiotensin converting enzyme 2 (ACE2)-binding viruses that we call "ABVs". The World Health Organization (WHO) and others are performing randomized controlled trials (RCTs) of vaccines and novel antivirals to address SARS-CoV-2 directly. Howev…

This study is evaluating whether a drug called ANA001 may help treat patients with a certain type of lung cancer.

Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

This study is a phase I /II adaptive clinical trial to evaluate the safety, tolerability and the Immunogenicity of Ad5-nCoV in healthy adults from 18 to <55 and 65 to <85 years of age，with the randomized, observer-blind, dose-escalation design

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Power

Coronavirus Clinical Trials 2022

Coronavirus studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect coronavirus clinical trial in 2022.

Relevant Clinical Trials

Top Oncology Trials

Popular Clinical Trials